The Sivec-Cooperman models of SARS-CoV-2 and SARS-CoV/HIV-1 genomes demonstrate that HIV-1 develops compensatory mutations that can restore its reduced fitness and outsmart vacine antagonists
Note from the editor
The Sivec-Cooperman models of SARS-CoV-2 and SARS-CoV/HIV-1 genomes demonstrate that HIV-1 develops compensatory mutations that can restore its reduced fitness and outsmart vacine antagonists